Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 4/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | BLM | P54132 | 1/20 | 0.43 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.43 |
| ▸ | GNPAT | O15228 | 1/20 | 0.40 |
| ▸ | NOD1 | Q9Y239 | 4/20 | 0.39 |
| ▸ | MMP2 | P08253 | 2/20 | 0.36 |
| ▸ | MMP9 | P14780 | 2/20 | 0.36 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.36 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | C3AR1 | Q16581 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8139 | 0.89 | KMT2A (0.50) | FOLH1KMT2AALOX15BLMPMP22 | |
| SCHEMBL154381 | 0.89 | KMT2A (0.50) | FOLH1KMT2AALOX15BLMPMP22 | |
| SCHEMBL8140 | 0.89 | KMT2A (0.50) | FOLH1KMT2AALOX15BLMPMP22 | |
| Hydrochloric Acid SCHEMBL22978412 | 0.88 | KMT2A (0.48) | FOLH1KMT2AALOX15BLMPMP22 | |
| SCHEMBL30423570 | 0.88 | KMT2A (0.48) | FOLH1KMT2AALOX15BLMPMP22 | |
| Hydrochloric Acid SCHEMBL23834101 | 0.88 | KMT2A (0.48) | FOLH1KMT2AALOX15BLMPMP22 | |
| Hydrochloric Acid SCHEMBL5408064 | 0.88 | KMT2A (0.48) | FOLH1KMT2AALOX15BLMPMP22 | |
| SCHEMBL9089358 | 0.85 | FOLH1 (0.47) | FOLH1GNPATRIMKLANAALAD2 | |
| SCHEMBL6440048 | 0.85 | FOLH1 (0.47) | FOLH1GNPATRIMKLANAALAD2 | |
| SCHEMBL6440389 | 0.85 | FOLH1 (0.47) | FOLH1GNPATRIMKLANAALAD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250296915-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2025-09-25 | — | — | US | claimed |
| US-20250296915-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2025-09-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250296915-A1 | NOVEL AMINO ACID DERIVATIVES | DNPEP, BCAT1, ANPEP | FOLH1 239/4885KMT2A 2979/4885ALOX15 4829/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.